Are young infants treated with erythromycin at risk for developing hypertrophic pyloric stenosis?

Arch Dis Child. 2007 Mar;92(3):271-3. doi: 10.1136/adc.2006.110007.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Erythromycin / adverse effects*
  • Humans
  • Infant
  • Pyloric Stenosis, Hypertrophic / chemically induced*
  • Risk Factors
  • Whooping Cough / drug therapy

Substances

  • Anti-Bacterial Agents
  • Erythromycin